LOGIN
CART
MY ACCOUNT
Redeem Quote
North America
Albania
Argentina
Australia
Austria
Belarus
Belgium
Bosnia
Brazil
Bulgaria
Canada
Chile
China
Colombia
Costa Rica
Croatia
Cyprus
Czech Republic
Denmark
Dominican Republic
Ecuador
Egypt
Estonia
Finland
France
French Polynesia
Germany
Greece
Guatemala
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Jordan
Kenya
Korea
Kuwait
Latvia
Lebanon
Lithuania
Luxembourg
Macau
Macedonia
Malaysia
Malta
Mexico
Moldova
Morocco
Netherlands
New Zealand
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Romania
Russian Federation
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Venezuela
Vietnam
Yemen
Yugoslavia
Zimbabwe
Gene Search
Antigen Profiler
BLAST
Product Search
Enter search terms and hit enter or click the submit button.
Click here
for help with large gene lists
Single letter AA sequence:
Score:
Advanced Peptide Design
Nucleotide
Peptide
(enter accession number or fasta sequence)
Database:
(choose database)
ALL Mammalian
ALL Non-mammalian
Homo sapiens
Mus Musculus
Rat
Canine
Primate
Bos Taurus
Danio rerio
Drosophila (All) (rel.1)
Fugu rubripes (All) (rel.1)
Macaca mulatta (All) (rel.1)
C. jejuni (All) (rel.1)
Xenopus laevis
Xenopus tropicalis
Incyte (All Species)
Submitted
0
Complete
0
Advanced (more options)
Recent Searches
Recent searches
Part of Thermo Fisher Scientific
Products
Promotions
Programs
Distributors
Support
Who We Are
Contact Us
Home
|
RNAi
|
MicroRNA-adapted Retroviral Ve
|
Single copy knockdown with LMP
Single copy knockdown with LMP
Transcription of shRNAmir from RNA Polymerase II (Pol II) promoters is sufficient for highly effective knockdown of a target gene, even when expressed at single copy. This feature is essential for RNAi screens using complex libraries where infected cells are unlikely to contain multiple copies of a given shRNAmir vector.
To determine whether the LTR promoter, a strong Pol II promoter was sufficient for effective gene knockdown using shRNAmirs, an shRNAmir to p53 (p53.1224) was introduced into the LMP (MSCV/LTRmiR30-PIG) vector. To facilitate comparison, LUMP (U6 promoter/miR-30PIG)-p53, UMP (U6 promoter, miR-30PIG-SIN-LTR)-p53 were introduced into NIH3T3 cells at a low multiplicity of infection (<5% efficiency) such that most transduced cells contained single or low copy proviral integrations. Both vectors carrying the MSCV-LTR supressed Trp53 extremely efficiently and were superior to UMP-p53.1224 which expresses p53 from the U6 promoter alone (from Dickens
et al
2005).
Figure 1) Western blot analysis for Trp53 expression in NIH3T3 cells transduced at less than 5% efficiency (assessed by GFP FACS) with LMP and other retroviral Pol II vectors
References:
Dickens NG
et al
(2005) "Probing tumor phenotypes using stable and regulated synthetic microRNA precursors" Nature Genetics Vol 37, No 11 1289-1295.